Kodiak Sciences (KOD) Research & Development (2017 - 2026)
Kodiak Sciences (KOD) reported Research & Development of $48.5 million for Q1 2026, up 11.23% on a YoY basis from $43.6 million in Q1 2025, and up 6.71% quarter-over-quarter from $45.5 million in Q4 2025.
Kodiak Sciences (KOD) Research & Development (2017 - 2026) Analysis & Trends
Kodiak Sciences has reported Research & Development for 10 years, with the latest figure at $48.5 million in Q1 2026.
- For the quarter ending Q1 2026, Research & Development rose 11.23% year-over-year to $48.5 million; the trailing twelve-month figure through Mar 2026 stood at $187.3 million (up 33.95% YoY), and the FY2025 full-year result was $182.4 million, up 44.63% from the prior year.
- Research & Development for Q1 2026 stood at $48.5 million, up from $45.5 million in the prior quarter.
- The five-year high for Research & Development was $76.2 million in Q1 2022, with the low at $29.9 million in Q1 2024.
- Historically, Research & Development has averaged $48.9 million across 5 years, with a median of $46.6 million in 2023.
- Annual changes were most pronounced in 2022 — Research & Development surged 88.85% — and 2024, when it sank 51.44%.
- Kodiak Sciences' Research & Development stood at $56.0 million in 2022, then slipped by 16.73% to $46.6 million in 2023, then tumbled by 31.86% to $31.8 million in 2024, then surged by 43.19% to $45.5 million in 2025, then climbed by 6.71% to $48.5 million in 2026.
- The last three Research & Development figures came in at $48.5 million (Q1 2026), $45.5 million (Q4 2025), and $50.5 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 762,369.55 Bn | 762,369.51 Bn | - | 4.32 Mn |
| 2 | Belite Bio | 55,096.00 Bn | 55,096.00 Bn | - | 15.66 Mn |
| 3 | Quantum Biopharma | 17,755.80 Bn | 17,755.79 Bn | - | 626,092.00 |
| 4 | Legend Biotech | 3,486.00 Bn | 3,485.71 Bn | 242.10 Mn | -101.30 Mn |
| 5 | Akari Therapeutics | 1,737.42 Bn | 1,737.41 Bn | - | 1.46 Mn |
| 6 | Evaxion A | 1,551.28 Bn | 1,551.26 Bn | - | -2.30 Mn |
| 7 | Psyence Biomedical | 227.32 Bn | 227.31 Bn | - | 357,444.00 |
| 8 | Vertex Pharmaceuticals | 110.84 Bn | 103.59 Bn | 2.59 Bn | 961.60 Mn |
| 9 | Abivax | 91.71 Bn | 91.71 Bn | - | -58.00 Mn |
| 10 | Kodiak Sciences | 1.95 Bn | 1.95 Bn | - | 48.55 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 48.55 Mn |
| Dec 31, 2025 | 45.49 Mn |
| Sep 30, 2025 | 50.48 Mn |
| Jun 30, 2025 | 42.76 Mn |
| Mar 31, 2025 | 43.64 Mn |
| Dec 31, 2024 | 31.77 Mn |
| Sep 30, 2024 | 31.88 Mn |
| Jun 30, 2024 | 32.51 Mn |
| Mar 31, 2024 | 29.93 Mn |
| Dec 31, 2023 | 46.63 Mn |
| Sep 30, 2023 | 36.19 Mn |
| Jun 30, 2023 | 66.96 Mn |
| Mar 31, 2023 | 56.52 Mn |
| Dec 31, 2022 | 55.99 Mn |
| Sep 30, 2022 | 61.68 Mn |
| Jun 30, 2022 | 73.74 Mn |
| Mar 31, 2022 | 76.18 Mn |
| Dec 31, 2021 | 75.60 Mn |
| Sep 30, 2021 | 56.00 Mn |
| Jun 30, 2021 | 45.40 Mn |